Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway. (Q37711241)
Jump to navigation
Jump to search
scientific article published on December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway. |
scientific article published on December 2012 |
Statements
Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway (English)
Abbas K Samadi
Joseph Bazzill
Xuan Zhang
Rob Gallagher
Hauping Zhang
Kelly Kindscher
Barbara Timmermann
1 December 2012
1 reference